Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses

Ítems similars

• The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M
  per: Tseng, Jeng-Sen, et al.
  Publicat: (2016)
• Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients
  per: Hsu, Kuo-Hsuan, et al.
  Publicat: (2021)
• Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma
  per: Su, Kang-Yi, et al.
  Publicat: (2018)
• EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
  per: Chen, Hsuan-Yu, et al.
  Publicat: (2016)
• Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma
  per: Tseng, Jeng-Sen, et al.
  Publicat: (2014)